The IIT Roorkee study on Efavirenz offers a new avenue for Chikungunya treatment, bringing optimism to patients and doctors ...
IIT Roorkee researchers have discovered that Efavirenz, an HIV drug, may help treat Chikungunya by reducing virus replication ...
The study conducted by IIT Roorkee is supported by the Indian Council of Medical Research (ICMR). It has been published in a ...
Taking proper precautions can significantly reduce the risk of infections, keep reading as we share some tips.
Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...
CNN has reached out to the CDC for comment. Chikungunya virus is typically spread to people through the bite of an infected mosquito. Most adults don’t receive the vaccine; it is sometimes ...
In the years to come, Bavarian Nordic foresees that more commercially minded-business taking the lead over the sort of ...
In January, the county launched a program designed to lower the mosquito population by sterilizing male mosquitos with low ...
Bhopal: Health authorities in Bhopal have intensified their monitoring and preventive efforts following a roughly 10% rise in chikungunya incidents du.
(WDTN) - Five people who recently received a vaccine that prevents a disease caused by chikungunya virus have been hospitalized. On Tuesday, the U.S. Centers for Disease Control and Prevention said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results